Category
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Today's News
More News
Liquid biopsy predicts early disease progression, potential survival in patients with advanced breast cancer

Liquid biopsy predicts early disease progression, potential survival in patients with advanced breast cancer

by Johns Hopkins UniversityCredit: Unsplash/CC0 Public DomainA novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict e

Liquid biopsy predicts early disease progression, potential survival in patients with advanced breast cancer

by Johns Hopkins UniversityCredit: Unsplash/CC0 Public DomainA novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict e
A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl

A comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries

by National Institutes of HealthTumor types and data types of the CPTAC pan-cancer dataset. Overview of the available molecular data types for the CPTAC pan-cancer cohort (n= 1072, see Tabl
Researchers discover a new approach to boost the immune system

Researchers discover a new approach to boost the immune system

by Aarhus UniversityCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteImmunotherapy is a type of cancer treatment that uses the body's own immune system to fight tumor cells. Whil

Researchers discover a new approach to boost the immune system

by Aarhus UniversityCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteImmunotherapy is a type of cancer treatment that uses the body's own immune system to fight tumor cells. Whil
Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ
Researchers make major advance with cancer-killing antibody-drug conjugates

Researchers make major advance with cancer-killing antibody-drug conjugates

by Doug Bennett,University of FloridaCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01771Building a new precision cancer treatment comes with no shortage of

Researchers make major advance with cancer-killing antibody-drug conjugates

by Doug Bennett,University of FloridaCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01771Building a new precision cancer treatment comes with no shortage of
Increasing incidence of early-onset colorectal precancerous lesions in patients under age 50

Increasing incidence of early-onset colorectal precancerous lesions in patients under age 50

by The Mount Sinai HospitalCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0In a study published in the journalGastroenterology, researchers at the Icahn Sch

Increasing incidence of early-onset colorectal precancerous lesions in patients under age 50

by The Mount Sinai HospitalCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0In a study published in the journalGastroenterology, researchers at the Icahn Sch
A novel pathway to target colorectal cancer

A novel pathway to target colorectal cancer

by Medical University of South CarolinaDr. Raymond N. Dubois, noted cancer researcher and dean of the College of Medicine at the Medical University of South Carolina, is senior author on the Gast

A novel pathway to target colorectal cancer

by Medical University of South CarolinaDr. Raymond N. Dubois, noted cancer researcher and dean of the College of Medicine at the Medical University of South Carolina, is senior author on the Gast
Ammonia levels do not aid management of hepatic encephalopathy in cirrhotic patients

Ammonia levels do not aid management of hepatic encephalopathy in cirrhotic patients

by Medical University of South CarolinaDon Rockey, M.D. is professor and chair of the Department of Medicine at the Medical University of South Carolina. Credit: Sarah PackThe liver performs seve

Ammonia levels do not aid management of hepatic encephalopathy in cirrhotic patients

by Medical University of South CarolinaDon Rockey, M.D. is professor and chair of the Department of Medicine at the Medical University of South Carolina. Credit: Sarah PackThe liver performs seve
Factors associated with nonresponse to FMT identified in IBS

Factors associated with nonresponse to FMT identified in IBS

For patients with irritable bowel syndrome (IBS), those who are male and/or have low Alistipes levels are more likely to be nonresponders to fecal microbiota transplantation (FMT), according to a stud

Factors associated with nonresponse to FMT identified in IBS

For patients with irritable bowel syndrome (IBS), those who are male and/or have low Alistipes levels are more likely to be nonresponders to fecal microbiota transplantation (FMT), according to a stud
Does TikTok's chia-lemon 'internal shower' really beat constipation? Here's what science says

Does TikTok's chia-lemon 'internal shower' really beat constipation? Here's what science says

by Clare Collins,The ConversationCredit: AI-generated imageHeard about the chia seed-lemon juice "internal shower" drink? It's going viral on TikTok and is being hailed as a digest

Does TikTok's chia-lemon 'internal shower' really beat constipation? Here's what science says

by Clare Collins,The ConversationCredit: AI-generated imageHeard about the chia seed-lemon juice "internal shower" drink? It's going viral on TikTok and is being hailed as a digest
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...